|
Volumn 56, Issue 2, 2006, Pages 201-208
|
Mechanisms of EBV-mediated oncogenesis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS;
EBV ENCODED NUCLEAR ANTIGEN 1;
EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS;
EBV-ENCODED NUCLEAR ANTIGEN 1;
EPSTEIN BARR VIRUS ANTIGEN;
EPSTEIN BARR VIRUS ENCODED RNA 1;
EPSTEIN BARR VIRUS ENCODED RNA 2;
EPSTEIN-BARR VIRUS ENCODED RNA 1;
EPSTEIN-BARR VIRUS ENCODED RNA 2;
MATRIX PROTEIN;
UNCLASSIFIED DRUG;
VIRUS RNA;
ANIMAL;
B LYMPHOCYTE;
EPSTEIN BARR VIRUS;
GENETICS;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
NEOPLASM;
PATHOGENICITY;
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
VIROLOGY;
ANIMALS;
B-LYMPHOCYTES;
EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOCOMPROMISED HOST;
LYMPHOCYTE ACTIVATION;
NEOPLASMS;
RNA, VIRAL;
SIGNAL TRANSDUCTION;
VIRAL MATRIX PROTEINS;
|
EID: 34447281517
PISSN: 00426857
EISSN: None
Source Type: Journal
DOI: 10.2222/jsv.56.201 Document Type: Review |
Times cited : (4)
|
References (54)
|